Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
Lingge YangShuli WeiJingnan ZhangQiongjie HuWansong HuMengqing CaoLong ZhangYongfang WangPingli WangKai WangPublished in: Journal of translational medicine (2022)
IPTS molecular typing based on the degree of TIIC in the TME could well predict the efficacy of immunotherapy in patients with LUSC with a certain prognostic value.